SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-124434
Filing Date
2023-12-08
Accepted
2023-12-08 07:37:42
Documents
4
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2332441d1_6k.htm 6-K 18400
2 EXHIBIT 10.1 tm2332441d1_ex10-1.htm EX-10.1 468943
3 EXHIBIT 99.1 tm2332441d1_ex99-1.htm EX-99.1 12794
4 GRAPHIC tm2332441d1_ex10-1img001.jpg GRAPHIC 2879
  Complete submission text file 0001104659-23-124434.txt   505304
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 231473927
SIC: 2834 Pharmaceutical Preparations